News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Chris Smyth

Advertisement

Articles by Chris Smyth

Capitalizing On Collaboration and Confidence: Survey Insights and Expectations For Biotech in 2024

ByChris Smyth
February 2nd 2024

Dr. Chris Smyth, president of ICON Biotech, discusses emerging trends in the biotech space.

Advertisement

Latest Updated Articles

  • Capitalizing On Collaboration and Confidence: Survey Insights and Expectations For Biotech in 2024
    Capitalizing On Collaboration and Confidence: Survey Insights and Expectations For Biotech in 2024

    Published: February 2nd 2024 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor

2

JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back

3

Alnylam Announces $250 Million Investment in Massachusetts Facility

4

Pharmaceutical Executive Daily: Nine New Additions to TrumpRx

5

President Trump Announces Nine More TrumpRx Participants

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us